98%
921
2 minutes
20
Targeting glutamatergic neurons is critical for understanding brain functions and treating neurological disorders linked to glutamate dysregulation. However, existing methods face challenges including low specificity, slow kinetics, poor blood-brain barrier (BBB) penetration, and reliance on transgenic pathways. Here, we report the cyanobacterial ferredoxin-dependent glutamate synthase (Fd-GOGAT) as a non-transgenic, multifunctional platform for rapid and selective targeting of glutamatergic neurons in vivo. We demonstrate the high affinity of Fd-GOGAT to glutamatergic neuron membranes that allows for fixation-free labeling within 1-2 h, and its self-deliverable BBB-crossing capability via systemic administration in living mice. When conjugated with functional motifs (e.g., fluorophores or photosensitizers), Fd-GOGAT enables in vivo glutamatergic neuron-targeted imaging and neuromodulation, displaying region-specific enrichment in glutamate-dependent brain circuits and light-responsive neuron inhibition through intravenous delivery of photodynamic conjugates. This platform addresses longstanding barriers for direct neuron targeting and manipulation in vivo, proving its adaptability for versatile applications by chemical functionalization and potential transformative value in glutamate-centered fundamental research and clinical translation.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1002/anie.202506692 | DOI Listing |
J Trace Elem Med Biol
September 2025
Department of Neurobiology, Maj Institute of Pharmacology, Polish Academy of Sciences, Smętna 12, Kraków 31-343, Poland. Electronic address:
Vanadium (V) is a trace element in the environment; it is detected in soil, water, air, dust, and food products. V-containing compounds have shown therapeutic potential in the treatment of diabetes. However, studies on the effects of V on animal behavior remain limited and sporadic.
View Article and Find Full Text PDFPsychopharmacology (Berl)
September 2025
Institute of Cardiovascular Research, Sleep Medical Center, Department of Psychiatry, Fundamental and Clinical Research on Mental Disorders Key Laboratory of Luzhou, Affiliated Hospital, Southwest Medical University, Luzhou, Sichuan Province, 646000, China.
Rationale: Genome-wide association studies (GWASs) are used to identify genetic variants for association with schizophrenia (SCZ) risk; however, each GWAS can only reveal a small fraction of this association.
Objectives: This study systematically analyzed multiple GWAS data sets to identify gene subnetwork and pathways associated with SCZ.
Methods: We identified gene subnetwork using dmGWAS program by combining SCZ GWASs and a human interaction network, performed gene-set analysis to test the association of gene subnetwork with clinical symptom scores and disease state, meanwhile, conducted spatiotemporal and tissue-specific expression patterns and cell-type-specific analysis of genes in the subnetwork.
Br J Pharmacol
September 2025
Department of Pharmacology, College of Pharmacy, China Pharmaceutical University, Nanjing, China.
Background And Purpose: The pathological role of the bile acid receptor TGR5/GPBA in Alzheimer's disease (AD) is not fully understood. We investigated the pharmacological effects and mechanisms of TGR5 in AD model mice.
Experimental Approach: TGR5 expression was assessed in AD mice using immunofluorescence and immunoblotting.
Commun Biol
September 2025
Department of Molecular Neurobiology, Max Planck Institute for Multidisciplinary Sciences, Göttingen, Germany.
Neuronal development and function are orchestrated by a plethora of regulatory mechanisms that control the abundance, localization, interactions, and function of proteins. A key role in this regard is assumed by post-translational protein modifications (PTMs). While some PTM types, such as phosphorylation or ubiquitination, have been explored comprehensively, PTMs involving ubiquitin-like modifiers (Ubls) have remained comparably enigmatic (Ubls).
View Article and Find Full Text PDFJ Neurosci
September 2025
Lendület Laboratory of Thalamus Research, HUN-REN Institute of Experimental Medicine; Budapest, Hungary
The paraventricular thalamic nucleus (PVT) integrates subcortical signals related to arousal, stress, addiction, and anxiety with top-down cortical influences. Increases or decreases in PVT activity exert profound, long-lasting effects on behavior related to motivation, addiction and homeostasis. Yet the sources of its subcortical excitatory and inhibitory afferents, their distribution within the PVT, and their integration with layer-specific cortical inputs remain unclear.
View Article and Find Full Text PDF